T1	p 148 150	UK
T2	p 275 283	patients
T3	p 295 308	cophenylcaine
T4	p 312 325	placebo nasal
T5	p 332 362	before flexible nasendoscopy .
T6	i 6 37	Cophenylcaine spray vs. placebo
T7	i 165 184	topical preparation
T8	i 194 202	flexible
T9	i 214 226	nasendoscopy
T10	i 295 362	cophenylcaine or placebo nasal spray before flexible nasendoscopy .
T11	i 967 980	cophenylcaine
T12	o 365 396	visual analogue scale ( 1-100 )
T13	o 409 469	record pain , unpleasantness of taste and overall discomfort
T14	o 482 483	.
T15	o 528 555	minimal pain and discomfort
T16	o 612 638	pain or overall discomfort
T17	o 690 712	sensation of bad taste
T18	o 816 838	overall unpleasantness
T19	o 872 930	pain experienced and secondarily unpleasantness of taste .